Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes

被引:83
|
作者
Shalhub, Sherene [1 ]
Black, James H., III [2 ]
Cecchi, Alana C. [3 ]
Xu, Zhi [4 ]
Griswold, Ben F. [4 ]
Safi, Hazim J. [5 ]
Milewicz, Dianna M. [3 ]
McDonnell, Nazli B. [4 ]
机构
[1] Univ Washington, Dept Gen Surg, Div Vasc Surg, Seattle, WA 98195 USA
[2] Johns Hopkins Univ Hosp, Dept Surg, Div Vasc Surg & Endovasc Therapy, Baltimore, MD 21287 USA
[3] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Med Genet, Houston, TX 77030 USA
[4] NIA, Baltimore, MD 21224 USA
[5] Univ Texas Med Sch Houston, Dept Cardiothorac & Vasc Surg, Houston, TX USA
关键词
SYNDROME TYPE-IV; COL3A1; GENE; MUTATIONS; MANAGEMENT; CELIPROLOL;
D O I
10.1016/j.jvs.2014.01.070
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The management of arterial pathology in individuals with vascular Ehlers-Danlos syndrome (vEDS) remains a challenge. Here we describe the correlation between COL3A1 gene mutation type and the clinical phenotype in individuals with vEDS. Methods: Individuals with confirmed molecular diagnoses of vEDS were enrolled in a multi-institutional natural history study. Data collected included demographics, clinical and family histories, arterial pathology (aneurysm, dissection, and rupture), operative details, and autopsy reports. Individuals were classified into two cohorts by the type of COL3A1 mutations and their effect on the amount of normal collagen produced: those with mutations that lead to minimal (MIN) production (10%-15%) of normal type III collagen and those with haploinsufficiency (HI) mutations that lead to production of 50% of the normal type III collagen. Results: A cohort of 68 individuals (72%) from 56 families had arterial pathology (44% male) with 13% HI. The HI group was older at the time of their first vascular event (mean, 42 [range, 26-58] years vs 33 [range, 8-62] years; P = .016) and had a higher incidence of aortic pathology than the MIN group (56% vs 21%; P = .025). Visceral arterial pathology was seen in 43 arteries in 23 individuals in the MIN group vs only one artery in five individuals in the HI group. Emergency surgical procedures were more likely to be undertaken when vEDS diagnosis was not known (81% vs 41%; P = .005), and 81% of these procedures were open surgical repair compared with 19% endovascular repairs (P = .019). Open and endovascular repairs were equally used in the elective setting. Postoperative complications were highest when the diagnosis of vEDS was not known (62% vs 14%; P < .001) and when procedures were undertaken in an emergency setting (5% vs 55% P < .001). Mortality due to arterial complications was 0% in the HI cohort and 21% in the MIN cohort (P = .132). Conclusions: Arterial pathology in vEDS individuals is related to the underlying COL3A1 mutation type. The arterial pathology in individuals with HI mutations occurs at later ages with a higher incidence of aortic disease compared with other COL3A1 mutation types. Molecular diagnosis is recommended because diagnosis confirmation, appropriate surveillance, and prophylactic interventions in an elective setting improve surgical outcomes.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [21] VASCULAR COMPLICATIONS IN THE EHLERS-DANLOS SYNDROME
    KROG, M
    ALMGREN, B
    ERIKSSON, I
    NORDSTROM, S
    ACTA CHIRURGICA SCANDINAVICA, 1983, 149 (03): : 279 - 282
  • [22] Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome
    Byers, Peter H.
    Belmont, John
    Black, James
    De Backer, Julie
    Frank, Michael
    Jeunemaitre, Xavier
    Johnson, Diana
    Pepin, Melanie
    Robert, Leema
    Sanders, Lynn
    Wheeldon, Nigel
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2017, 175 (01) : 40 - 47
  • [23] Ehlers-Danlos Syndrome: A Diagnosis to be Considered
    Morais, P.
    Peralta, L.
    Sousa, S.
    Silva, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 23 - 23
  • [24] Audiologic Outcomes in Ehlers-Danlos Syndrome
    Weir, Forest W.
    Hatch, Jonathan L.
    Muus, John S.
    Wallace, Sarah A.
    Meyer, Ted A.
    OTOLOGY & NEUROTOLOGY, 2016, 37 (06) : 748 - 752
  • [25] A diagnosis of vascular ehlers-danlos syndrome in childhood: clinical and molecular features of 63 individuals
    Wilkinson, N.
    Cervi, E.
    Wagner, B.
    Von Klemperer, K.
    Andrew, T.
    Ghali, N.
    Van Dijk, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] A diagnosis of vascular ehlers-danlos syndrome in childhood: clinical and molecular features of 63 individuals
    Wilkinson, N.
    Cervi, E.
    Wagner, B.
    Von Klemperer, K.
    Andrew, T.
    Ghali, N.
    Van Dijk, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [27] Vascular Ehlers-Danlos Syndrome Exploring the Role of Inflammation in Arterial Disease
    Milewicz, Dianna M.
    Reid, Amy J.
    Cecchi, Alana C.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (01) : 5 - 7
  • [28] The molecular genetics of the Ehlers-Danlos syndrome
    Burrows, NP
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1999, 24 (02) : 99 - 106
  • [29] MOLECULAR DEFECTS IN THE EHLERS-DANLOS SYNDROME
    PINNELL, SR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 79 : S90 - S92
  • [30] EHLERS-DANLOS SYNDROME WITH MULTIPLE ARTERIAL LESIONS
    IMAHORI, S
    BANNERMAN, RM
    GRAF, CJ
    BRENNAN, JC
    AMERICAN JOURNAL OF MEDICINE, 1969, 47 (06): : 967 - +